What is Zymeworks's AOCI?

Zymeworks (ZYME) reported AOCI of -$6.57M in Q1 2026.

How has Zymeworks's AOCI changed year-over-year?

Zymeworks's AOCI decreased by 2.5% year-over-year, from -$6.41M to -$6.57M.

What is the long-term trend for Zymeworks's AOCI?

Over 4 years (2021 to 2025), Zymeworks's AOCI has grown at a -2.3% compound annual growth rate (CAGR), from -$6.66M to -$6.08M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Zymeworks ZYME AOCI

AOCI at other companies

PfizerPFE

-$7.2B+16.1%

AmgenAMGN

-$190M+17.7%

AnaptysBio, Inc.ANAB

-$146K-191%

Viridian Therapeutics, Inc.VRDN

-$558K-328%

AbCellera Biologics Inc.ABCL

-$2.42M+65.4%

Stoke Therapeutics, Inc.STOK

-$115K-10.6%

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.79B+125%

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's AOCI?: Zymeworks (ZYME) reported AOCI of -$6.57M in Q1 2026.
How has Zymeworks's AOCI changed year-over-year?: Zymeworks's AOCI decreased by 2.5% year-over-year, from -$6.41M to -$6.57M.
What is the long-term trend for Zymeworks's AOCI?: Over 4 years (2021 to 2025), Zymeworks's AOCI has grown at a -2.3% compound annual growth rate (CAGR), from -$6.66M to -$6.08M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.